, 75 , 2765-2774, Law, B
Contraindications: Mechanical obstruction: should not be given to patients having any form of mechanical obstruction in the GI tract or bladder Compromised GI or Bladder Wall Integrity : should not be given to patients where the integrity of the gastrointestinal or bladder wall is in question Hypersensitivity to bethanechol chloride tablets, Hyperthyroidism Peptic ulcer Latent or active bronchial asthma, Pronounced bradycardia or hypotension Vasomotor instability Coronary artery disease Epilepsy Parkinsonism Side Effects: Early signs of overdosage are abdominal discomfort, blurred vision, salivation, flushing of the skin (hot feeling), sweating, nausea and vomiting ( SLUDE-like symptoms ) 2) , bronchoconstriction, increased stomach acid secretion, hypotension
Methods Selection of studies for review The inclusion criteria for studies were defined as: (a) participants diagnosed with an autism spectrum disorder using standardised criteria such as the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV-R [51] or the Childhood Autism Rating Scale (CARS) scores [52]
A key role for an impaired detoxification mechanism in the etiology and severity of autism spectrum disorders
KCl 2.7 mM, KH 2 PO 4 1.5 mM, NaCl 136 mM, Na 2 HPO 4 2 H 2 O 6.5 mM, pH 7.4) containing 3% bovine serum albumin (BSA-PBS) for 1 h at room temperature and were then incubated with a rabbit anti-claudin 5 primary antibody diluted in 3% BSA-PBS (1:300) overnight at 4 C
